Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate

Patent No. EP3050556 (titled "Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate") was filed by Teva Pharmaceuticals on Sep 24, 2015. The application was issued on Mar 22, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UK TRADING MYLANDec 22, 2017GILL JENNINGS & EVERY
WITTKOPPDec 21, 2017HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3050556

TEVA PHARMACEUTICALS
Application Number
EP15186721A
Filing Date
Sep 24, 2015
Status
Revoked
Dec 18, 2020
Publication Date
Mar 22, 2017